Objectives

After participating in this educational activity, attendees should be able to:

1|Explain pathophysiology of CF and its impact on pregnancy

2|Recognize maternal complications and pregnancy related risks in CF patients

3|Discuss fetal implications, including perinatal outcomes and inheritance risks

4|Review best practices for managing pregnancy in CF patients

5|Discuss the differential diagnosis for a newborn presenting with bilious emesis

6|Recognize presentation of CF in newborns

 

Presenter(s): 

Nadia Kianfar, MD
OB Resident/PGYII
UMass Chan Medical School-Baystate Medical Center

Avery Roland, MD
Pediatric Resident/PGYI
UMass Chan Medical School-Baystate Medical Center

Yara Kassamani, MD
Pediatric Resident/PGYI
UMass Chan Medical School-Baystate Medical Center

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Nadia Kianfar, MDSpeakerNo relevant relationships with ineligible companies to discloseNo
Avery Ronald, MDSpeaker
No relevant relationships with ineligible companies to disclose
No
Yara Kassamani, MDSpeaker
No relevant relationships with ineligible companies to disclose
No
Session date: 
02/13/2025 - 12:15pm to 1:00pm EST
Location: 
ZOOM via invite
759 Chestnut Street
Baystate Medical Center
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.